MTAP and glioblastoma: However, our data of profiling GBM tumors from two different dataset (HF series and MDA series) demonstrate that there are nonsignificant 1.4-fold (p = 0.2) and 1.14-fold (p = 0.9) increase in MTA levels in MTAP-deleted tumors versus intact ones.